291 related articles for article (PubMed ID: 37815662)
1. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.
Banaszek N; Kurpiewska D; Kozak K; Rutkowski P; Sobczuk P
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17635-17649. PubMed ID: 37815662
[TBL] [Abstract][Full Text] [Related]
2. SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.
Lézot F; Corre I; Morice S; Rédini F; Verrecchia F
Cells; 2020 Feb; 9(3):. PubMed ID: 32110934
[TBL] [Abstract][Full Text] [Related]
3. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
4. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
5. Insight into the Etiology of Undifferentiated Soft Tissue Sarcomas from a Novel Mouse Model.
Fleming JT; Brignola E; Chen L; Guo Y; Zhao S; Wang Q; Li B; Correa H; Ermilov AN; Dlugosz AA; Chiang C
Mol Cancer Res; 2019 May; 17(5):1024-1035. PubMed ID: 30683671
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
[TBL] [Abstract][Full Text] [Related]
7. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
[TBL] [Abstract][Full Text] [Related]
8. Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma.
Kelleher FC; Cain JE; Healy JM; Watkins DN; Thomas DM
Pharmacol Ther; 2012 Nov; 136(2):153-68. PubMed ID: 22906929
[TBL] [Abstract][Full Text] [Related]
9. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
10. Cabozantinib as an emerging treatment for sarcoma.
Schöffski P; Blay JY; Ray-Coquard I
Curr Opin Oncol; 2020 Jul; 32(4):321-331. PubMed ID: 32541320
[TBL] [Abstract][Full Text] [Related]
11. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
12. A role for maintenance therapy in managing sarcoma.
Ray-Coquard I; Le Cesne A
Cancer Treat Rev; 2012 Aug; 38(5):368-78. PubMed ID: 21843915
[TBL] [Abstract][Full Text] [Related]
13. Use of chemotherapy for patients with bone and soft-tissue sarcomas.
Wesolowski R; Budd GT
Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S23-6. PubMed ID: 20179184
[TBL] [Abstract][Full Text] [Related]
14. Sarcoma Stem Cell Heterogeneity.
Hatina J; Kripnerova M; Houfkova K; Pesta M; Kuncova J; Sana J; Slaby O; Rodríguez R
Adv Exp Med Biol; 2019; 1123():95-118. PubMed ID: 31016597
[TBL] [Abstract][Full Text] [Related]
15. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Bennani-Baiti IM; Machado I; Llombart-Bosch A; Kovar H
Hum Pathol; 2012 Aug; 43(8):1300-7. PubMed ID: 22245111
[TBL] [Abstract][Full Text] [Related]
16. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
17. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.
Tallroth K
Acta Radiol Suppl; 1976; 349():1-84. PubMed ID: 206099
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib for the Treatment of Sarcoma.
Blay JY; Duffaud F; George S; Maki RG; Penel N
Curr Treat Options Oncol; 2022 Nov; 23(11):1477-1502. PubMed ID: 36178573
[TBL] [Abstract][Full Text] [Related]
20. A highlight on Sonic hedgehog pathway.
Carballo GB; Honorato JR; de Lopes GPF; Spohr TCLSE
Cell Commun Signal; 2018 Mar; 16(1):11. PubMed ID: 29558958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
